KESTRA PRIVATE WEALTH SERVICES, LLC
Position in GRCE — Grace Therapeutics, Inc.
CIK 1649451
AUSTIN, TX
Position in GRCE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$52,210
-$7,980 QoQ
Shares Held
23,000
+76.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 33 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in GRCE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KESTRA PRIVATE WEALTH SERVICES, LLC holds $13,960,546 across 25 Biotechnology names. GRCE ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,539 | $5,235,037 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
50,588 | $2,379,659 | |
| 3 | INCY |
Incyte Corp
|
8,684 | $984,418 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,753 | $748,300 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
944 | $588,621 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
10,555 | $575,669 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
13,064 | $509,626 | |
| 8 | RPRX |
Royalty Pharma plc
|
7,881 | $441,887 |
All Filings in GRCE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,210 | 23,000 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $60,190 | 13,000 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||